MAUREEN GRACE STEWARD: Open Payments
NPI 1730961012 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$517 in 21 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $407 · 2025 $517
Food & beverage: $517
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 10 | $260 |
| AKEBIA THERAPEUTICS INC | 2 | $66 |
| Amgen Inc. | 2 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| Novartis Pharmaceuticals Corporation | 1 | $29 |
| KYOWA KIRIN, INC. | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| Calliditas Therapeutics US Inc. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: IBSRELA, Vafseo, Kerendia, Fabhalta, TAVNEOS, CRYSVITA, JARDIANCE, TARPEYO.
Industry payments across CA — which companies pay providers there.
